What is CAR T Cell Therapy?
IMF Chief Medical Officer Joseph Mikhael, MD, discusses CAR T-cell therapy (chimeric antigen receptor), an approach for targeting BCMA as part of multiple myeloma treatment.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE
Visit our website at: ...
